Surgical resection of hypopharynx and cervical esophageal cancer with a history of esophagectomy for thoracic esophageal cancer

Satoshi Ida, Masaru Morita, Yukiharu Hiyoshi, Keisuke Ikeda, Koji Ando, Yasue Kimura, Hiroshi Saeki, Eiji Oki, Tetsuya Kusumoto, Sei Yoshida, Torahiko Nakashima, Masayuki Watanabe, Hideo Baba, Yoshihiko Maehara

研究成果: ジャーナルへの寄稿記事

5 引用 (Scopus)

抄録

Background. Cancer of the hypopharynx and cervical esophagus (PhCe cancer) frequently develops synchronously or metachronously with esophageal cancer. The surgical approach is usually difficult, especially in metachronous PhCe cancer after esophagectomy. The purpose of this study was to clarify the treatment outcomes of patients with metachronous PhCe cancer with a history of esophagectomy. Methods. The subjects evaluated in this study were 14 patients with metachronous PhCe cancer who underwent pharyngo-laryngo-esophagectomy after subtotal esophagectomy and gastric tube pull-up for primary esophageal cancer. Results. Definitive chemoradiotherapy (CRT; radiation dose >50 Gy) was performed for primary laryngeal (n = 1), pharyngeal (n = 2), esophageal (n = 1), and recurrent esophageal cancer (n = 2). For seven patients with metachronous PhCe cancer, induction CRT (radiation dose <40 Gy) was performed. In all 14 patients, pharyngo-laryngo-esophagectomy was followed by free jejunal graft interposition with reconstruction of the jejunal vessels. Although postoperative complications developed in four patients, no perioperative death or necrosis of the reconstructed free jejunum occurred. The 2- and 5-year overall survival rates were 84 and 50 %, respectively. Conclusions. Pharyngo-laryngo- esophagectomy with free jejunal transfer is considered to be safe for metachronous PhCe cancer, even in patients with a history of CRT and esophagectomy.

元の言語英語
ページ(範囲)1175-1181
ページ数7
ジャーナルAnnals of Surgical Oncology
21
発行部数4
DOI
出版物ステータス出版済み - 4 2014

Fingerprint

Hypopharynx
Esophagectomy
Esophageal Neoplasms
Uterine Cervical Neoplasms
Thorax
Neoplasms
Radiation
Chemoradiotherapy
Jejunum
Stomach
Necrosis
Survival Rate
Transplants

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

これを引用

Surgical resection of hypopharynx and cervical esophageal cancer with a history of esophagectomy for thoracic esophageal cancer. / Ida, Satoshi; Morita, Masaru; Hiyoshi, Yukiharu; Ikeda, Keisuke; Ando, Koji; Kimura, Yasue; Saeki, Hiroshi; Oki, Eiji; Kusumoto, Tetsuya; Yoshida, Sei; Nakashima, Torahiko; Watanabe, Masayuki; Baba, Hideo; Maehara, Yoshihiko.

:: Annals of Surgical Oncology, 巻 21, 番号 4, 04.2014, p. 1175-1181.

研究成果: ジャーナルへの寄稿記事

Ida, S, Morita, M, Hiyoshi, Y, Ikeda, K, Ando, K, Kimura, Y, Saeki, H, Oki, E, Kusumoto, T, Yoshida, S, Nakashima, T, Watanabe, M, Baba, H & Maehara, Y 2014, 'Surgical resection of hypopharynx and cervical esophageal cancer with a history of esophagectomy for thoracic esophageal cancer', Annals of Surgical Oncology, 巻. 21, 番号 4, pp. 1175-1181. https://doi.org/10.1245/s10434-013-3454-z
Ida, Satoshi ; Morita, Masaru ; Hiyoshi, Yukiharu ; Ikeda, Keisuke ; Ando, Koji ; Kimura, Yasue ; Saeki, Hiroshi ; Oki, Eiji ; Kusumoto, Tetsuya ; Yoshida, Sei ; Nakashima, Torahiko ; Watanabe, Masayuki ; Baba, Hideo ; Maehara, Yoshihiko. / Surgical resection of hypopharynx and cervical esophageal cancer with a history of esophagectomy for thoracic esophageal cancer. :: Annals of Surgical Oncology. 2014 ; 巻 21, 番号 4. pp. 1175-1181.
@article{fc34cb3d6bac452a8c2be06d8fdd4601,
title = "Surgical resection of hypopharynx and cervical esophageal cancer with a history of esophagectomy for thoracic esophageal cancer",
abstract = "Background. Cancer of the hypopharynx and cervical esophagus (PhCe cancer) frequently develops synchronously or metachronously with esophageal cancer. The surgical approach is usually difficult, especially in metachronous PhCe cancer after esophagectomy. The purpose of this study was to clarify the treatment outcomes of patients with metachronous PhCe cancer with a history of esophagectomy. Methods. The subjects evaluated in this study were 14 patients with metachronous PhCe cancer who underwent pharyngo-laryngo-esophagectomy after subtotal esophagectomy and gastric tube pull-up for primary esophageal cancer. Results. Definitive chemoradiotherapy (CRT; radiation dose >50 Gy) was performed for primary laryngeal (n = 1), pharyngeal (n = 2), esophageal (n = 1), and recurrent esophageal cancer (n = 2). For seven patients with metachronous PhCe cancer, induction CRT (radiation dose <40 Gy) was performed. In all 14 patients, pharyngo-laryngo-esophagectomy was followed by free jejunal graft interposition with reconstruction of the jejunal vessels. Although postoperative complications developed in four patients, no perioperative death or necrosis of the reconstructed free jejunum occurred. The 2- and 5-year overall survival rates were 84 and 50 {\%}, respectively. Conclusions. Pharyngo-laryngo- esophagectomy with free jejunal transfer is considered to be safe for metachronous PhCe cancer, even in patients with a history of CRT and esophagectomy.",
author = "Satoshi Ida and Masaru Morita and Yukiharu Hiyoshi and Keisuke Ikeda and Koji Ando and Yasue Kimura and Hiroshi Saeki and Eiji Oki and Tetsuya Kusumoto and Sei Yoshida and Torahiko Nakashima and Masayuki Watanabe and Hideo Baba and Yoshihiko Maehara",
year = "2014",
month = "4",
doi = "10.1245/s10434-013-3454-z",
language = "English",
volume = "21",
pages = "1175--1181",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Surgical resection of hypopharynx and cervical esophageal cancer with a history of esophagectomy for thoracic esophageal cancer

AU - Ida, Satoshi

AU - Morita, Masaru

AU - Hiyoshi, Yukiharu

AU - Ikeda, Keisuke

AU - Ando, Koji

AU - Kimura, Yasue

AU - Saeki, Hiroshi

AU - Oki, Eiji

AU - Kusumoto, Tetsuya

AU - Yoshida, Sei

AU - Nakashima, Torahiko

AU - Watanabe, Masayuki

AU - Baba, Hideo

AU - Maehara, Yoshihiko

PY - 2014/4

Y1 - 2014/4

N2 - Background. Cancer of the hypopharynx and cervical esophagus (PhCe cancer) frequently develops synchronously or metachronously with esophageal cancer. The surgical approach is usually difficult, especially in metachronous PhCe cancer after esophagectomy. The purpose of this study was to clarify the treatment outcomes of patients with metachronous PhCe cancer with a history of esophagectomy. Methods. The subjects evaluated in this study were 14 patients with metachronous PhCe cancer who underwent pharyngo-laryngo-esophagectomy after subtotal esophagectomy and gastric tube pull-up for primary esophageal cancer. Results. Definitive chemoradiotherapy (CRT; radiation dose >50 Gy) was performed for primary laryngeal (n = 1), pharyngeal (n = 2), esophageal (n = 1), and recurrent esophageal cancer (n = 2). For seven patients with metachronous PhCe cancer, induction CRT (radiation dose <40 Gy) was performed. In all 14 patients, pharyngo-laryngo-esophagectomy was followed by free jejunal graft interposition with reconstruction of the jejunal vessels. Although postoperative complications developed in four patients, no perioperative death or necrosis of the reconstructed free jejunum occurred. The 2- and 5-year overall survival rates were 84 and 50 %, respectively. Conclusions. Pharyngo-laryngo- esophagectomy with free jejunal transfer is considered to be safe for metachronous PhCe cancer, even in patients with a history of CRT and esophagectomy.

AB - Background. Cancer of the hypopharynx and cervical esophagus (PhCe cancer) frequently develops synchronously or metachronously with esophageal cancer. The surgical approach is usually difficult, especially in metachronous PhCe cancer after esophagectomy. The purpose of this study was to clarify the treatment outcomes of patients with metachronous PhCe cancer with a history of esophagectomy. Methods. The subjects evaluated in this study were 14 patients with metachronous PhCe cancer who underwent pharyngo-laryngo-esophagectomy after subtotal esophagectomy and gastric tube pull-up for primary esophageal cancer. Results. Definitive chemoradiotherapy (CRT; radiation dose >50 Gy) was performed for primary laryngeal (n = 1), pharyngeal (n = 2), esophageal (n = 1), and recurrent esophageal cancer (n = 2). For seven patients with metachronous PhCe cancer, induction CRT (radiation dose <40 Gy) was performed. In all 14 patients, pharyngo-laryngo-esophagectomy was followed by free jejunal graft interposition with reconstruction of the jejunal vessels. Although postoperative complications developed in four patients, no perioperative death or necrosis of the reconstructed free jejunum occurred. The 2- and 5-year overall survival rates were 84 and 50 %, respectively. Conclusions. Pharyngo-laryngo- esophagectomy with free jejunal transfer is considered to be safe for metachronous PhCe cancer, even in patients with a history of CRT and esophagectomy.

UR - http://www.scopus.com/inward/record.url?scp=84896096180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896096180&partnerID=8YFLogxK

U2 - 10.1245/s10434-013-3454-z

DO - 10.1245/s10434-013-3454-z

M3 - Article

C2 - 24380922

AN - SCOPUS:84896096180

VL - 21

SP - 1175

EP - 1181

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 4

ER -